Industry Research Reports
Global AI-assisted Diagnostic Software Market Research Report 2026
Industry: Medical Care
Published Date: 2026-06-18
Pages: 109 Pages
Report ld: 6809369
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
AI-assisted Diagnostic Software Market Size(US$)
CAGR 2026-2032
12.4%
Market Size,2032
USD 4,298
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global AI-assisted Diagnostic Software market was valued at US$ 1876 million in 2025 and is anticipated to reach US$ 4298 million by 2032, at a CAGR of 12.4% from 2026 to 2032.
AI-assisted Diagnostic Software refers to medical device software that uses artificial intelligence, machine learning, deep learning, computer vision, and medical image processing algorithms to automatically identify, segment, measure, quantify, flag lesions, stratify risks, generate reports, or assist diagnosis based on medical imaging data such as CT, MRI, X-ray, ultrasound, mammography, fundus images, and pathology slides. These products usually do not replace physicians’ final diagnosis, but serve as intelligent assistive tools in radiology departments, clinical departments, and telemedicine settings. They help improve reading efficiency, reduce missed-diagnosis risks, optimize workflows, and promote diagnostic standardization. With the continued growth of medical imaging data, shortages of radiologists, uneven diagnostic capability across healthcare institutions, and accelerated healthcare digitalization, AI-assisted Diagnostic Software is evolving from single-disease algorithm tools into intelligent diagnostic platforms covering multi-modality, multi-organ, multi-disease, and full-process imaging management.The average gross profit margin of this product is 45%.
The market opportunities for Medical Imaging AI Software are driven by increasing imaging volumes, rising physician workload, hospital digital transformation, and gradually clearer regulatory pathways. GE HealthCare’s annual report disclosed the acquisition of MIM Software to strengthen AI-enabled image analysis and workflow tools, while Siemens Healthineers’ AI-Rad Companion is positioned to automatically post-process imaging datasets, reduce repetitive tasks, and support diagnostic precision. These developments show that global imaging leaders are positioning AI software as a core module in imaging ecosystem upgrades. For manufacturers, this product is not merely a single algorithm, but a digital entry point connecting imaging equipment, PACS, cloud platforms, reporting systems, and clinical pathways. It can help hospitals improve diagnostic efficiency, quality consistency, and operational capability with existing physician resources, giving the category strong platform and recurring service value.
The main challenges in this industry lie in clinical generalizability, regulatory validation, commercial closed-loop formation, and physician trust. AI imaging software may perform differently across device brands, scanning protocols, patient populations, disease profiles, and image quality levels, so algorithm robustness, real-world performance, and clinical boundaries must be continuously validated. The FDA continues to issue action plans and regulatory documents for AI/ML software as a medical device, while China’s NMPA is improving requirements for evaluation databases and algorithm change management for AI medical devices. This shows that regulatory focus is shifting from whether software can detect lesions to whether it is explainable, traceable, and continuously manageable. At the same time, hospitals care more about whether software can be embedded into real workflows, reduce physician burden, and create clear clinical value, rather than simply demonstrating algorithm accuracy. Without high-quality data, clinical evidence, and post-sales operational capability, products will struggle to scale.
Downstream demand is shifting from single-disease screening assistance toward multimodal imaging platforms, workflow automation, and regional healthcare collaboration. Large hospitals focus on integrated deployment of AI across CT, MRI, mammography, ultrasound, and pathology, expecting software to support automatic measurement, structured reporting, follow-up comparison, priority triage, and quality-control alerts. Primary hospitals need AI to improve initial screening capability and diagnostic consistency for common and frequently occurring diseases. Physical examination centers, internet hospitals, and regional imaging centers value batch reading, remote collaboration, and reporting efficiency. As hospital informatization evolves from “putting devices online” to “intelligent clinical workflow,” AI imaging software will gradually evolve from an assistive tool into critical infrastructure for radiology department efficiency, clinical pathway management, and specialty service capability.
This report delivers a comprehensive overview of the global AI-assisted Diagnostic Software market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI-assisted Diagnostic Software. The AI-assisted Diagnostic Software market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global AI-assisted Diagnostic Software market comprehensively. Regional market sizes by Type, by Application, by Indication / Technology, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist AI-assisted Diagnostic Software manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- GE HealthCare
- Siemens Healthineers
- Philips Healthcare
- United Imaging Intelligence
- InferVision
- Deepwise
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- CT Imaging AI
- MRI Imaging AI
- X-ray Imaging AI
- Ultrasound AI
- Workflow Triage Software
Segment by Application
- Radiology Department
- Emergency Department
- Cancer Screening
- Chronic Disease Management
- Health Checkup
Segment by Category
- Lesion Detection
- Image Segmentation
- Quantitative Analysis
- Clinical Decision Support
Segment by Division
- Cloud-based Software
- On-premise Software
- Embedded AI Module
- SaaS Platform
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Indication / Technology, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for AI-assisted Diagnostic Software companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-assisted Diagnostic Software Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 CT Imaging AI
1.2.3 MRI Imaging AI
1.2.4 X-ray Imaging AI
1.2.5 Ultrasound AI
1.2.6 Workflow Triage Software
1.3 Market by Indication / Technology
1.3.1 Global AI-assisted Diagnostic Software Market Size Growth Rate by Indication / Technology: 2021 vs 2025 vs 2032
1.3.2 Lesion Detection
1.3.3 Image Segmentation
1.3.4 Quantitative Analysis
1.3.5 Clinical Decision Support
1.4 Market by Product Form / Mechanism
1.4.1 Global AI-assisted Diagnostic Software Market Size Growth Rate by Product Form / Mechanism: 2021 vs 2025 vs 2032
1.4.2 Cloud-based Software
1.4.3 On-premise Software
1.4.4 Embedded AI Module
1.4.5 SaaS Platform
1.5 Market by Application
1.5.1 Global AI-assisted Diagnostic Software Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Radiology Department
1.5.3 Emergency Department
1.5.4 Cancer Screening
1.5.5 Chronic Disease Management
1.5.6 Health Checkup
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global AI-assisted Diagnostic Software Market Perspective (2021–2032)
2.2 Global AI-assisted Diagnostic Software Growth Trends by Region
2.2.1 Global AI-assisted Diagnostic Software Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 AI-assisted Diagnostic Software Historic Market Size by Region (2021–2026)
2.2.3 AI-assisted Diagnostic Software Forecasted Market Size by Region (2027–2032)
2.3 AI-assisted Diagnostic Software Market Dynamics
2.3.1 AI-assisted Diagnostic Software Industry Trends
2.3.2 AI-assisted Diagnostic Software Market Drivers
2.3.3 AI-assisted Diagnostic Software Market Challenges
2.3.4 AI-assisted Diagnostic Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-assisted Diagnostic Software Players by Revenue
3.1.1 Global Top AI-assisted Diagnostic Software Players by Revenue (2021–2026)
3.1.2 Global AI-assisted Diagnostic Software Revenue Market Share by Players (2021–2026)
3.2 Global Top AI-assisted Diagnostic Software Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by AI-assisted Diagnostic Software Revenue
3.4 Global AI-assisted Diagnostic Software Market Concentration Ratio
3.4.1 Global AI-assisted Diagnostic Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-assisted Diagnostic Software Revenue in 2025
3.5 Global Key Players of AI-assisted Diagnostic Software Head Offices and Areas Served
3.6 Global Key Players of AI-assisted Diagnostic Software, Products and Applications
3.7 Global Key Players of AI-assisted Diagnostic Software, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 AI-assisted Diagnostic Software Breakdown Data by Type
4.1 Global AI-assisted Diagnostic Software Historic Market Size by Type (2021–2026)
4.2 Global AI-assisted Diagnostic Software Forecasted Market Size by Type (2027–2032)
5 AI-assisted Diagnostic Software Breakdown Data by Application
5.1 Global AI-assisted Diagnostic Software Historic Market Size by Application (2021–2026)
5.2 Global AI-assisted Diagnostic Software Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America AI-assisted Diagnostic Software Market Size (2021–2032)
6.2 North America AI-assisted Diagnostic Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America AI-assisted Diagnostic Software Market Size by Country (2021–2026)
6.4 North America AI-assisted Diagnostic Software Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-assisted Diagnostic Software Market Size (2021–2032)
7.2 Europe AI-assisted Diagnostic Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe AI-assisted Diagnostic Software Market Size by Country (2021–2026)
7.4 Europe AI-assisted Diagnostic Software Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific AI-assisted Diagnostic Software Market Size (2021–2032)
8.2 Asia-Pacific AI-assisted Diagnostic Software Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific AI-assisted Diagnostic Software Market Size by Region (2021–2026)
8.4 Asia-Pacific AI-assisted Diagnostic Software Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America AI-assisted Diagnostic Software Market Size (2021–2032)
9.2 Latin America AI-assisted Diagnostic Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America AI-assisted Diagnostic Software Market Size by Country (2021–2026)
9.4 Latin America AI-assisted Diagnostic Software Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-assisted Diagnostic Software Market Size (2021–2032)
10.2 Middle East & Africa AI-assisted Diagnostic Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa AI-assisted Diagnostic Software Market Size by Country (2021–2026)
10.4 Middle East & Africa AI-assisted Diagnostic Software Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE HealthCare
11.1.1 GE HealthCare Company Details
11.1.2 GE HealthCare Business Overview
11.1.3 GE HealthCare AI-assisted Diagnostic Software Introduction
11.1.4 GE HealthCare Revenue in AI-assisted Diagnostic Software Business (2021–2026)
11.1.5 GE HealthCare Recent Development
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Company Details
11.2.2 Siemens Healthineers Business Overview
11.2.3 Siemens Healthineers AI-assisted Diagnostic Software Introduction
11.2.4 Siemens Healthineers Revenue in AI-assisted Diagnostic Software Business (2021–2026)
11.2.5 Siemens Healthineers Recent Development
11.3 Philips Healthcare
11.3.1 Philips Healthcare Company Details
11.3.2 Philips Healthcare Business Overview
11.3.3 Philips Healthcare AI-assisted Diagnostic Software Introduction
11.3.4 Philips Healthcare Revenue in AI-assisted Diagnostic Software Business (2021–2026)
11.3.5 Philips Healthcare Recent Development
11.4 United Imaging Intelligence
11.4.1 United Imaging Intelligence Company Details
11.4.2 United Imaging Intelligence Business Overview
11.4.3 United Imaging Intelligence AI-assisted Diagnostic Software Introduction
11.4.4 United Imaging Intelligence Revenue in AI-assisted Diagnostic Software Business (2021–2026)
11.4.5 United Imaging Intelligence Recent Development
11.5 InferVision
11.5.1 InferVision Company Details
11.5.2 InferVision Business Overview
11.5.3 InferVision AI-assisted Diagnostic Software Introduction
11.5.4 InferVision Revenue in AI-assisted Diagnostic Software Business (2021–2026)
11.5.5 InferVision Recent Development
11.6 Deepwise
11.6.1 Deepwise Company Details
11.6.2 Deepwise Business Overview
11.6.3 Deepwise AI-assisted Diagnostic Software Introduction
11.6.4 Deepwise Revenue in AI-assisted Diagnostic Software Business (2021–2026)
11.6.5 Deepwise Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
AI-assisted Diagnostic Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-assisted Diagnostic Software was estimated to be worth US$ 1876 million in 2025 and is projected to reach US$ 4298 million, growing at a CAGR of 12.4% from 2026 to 2032.
Published Date: 2026-07-09
Pages: 107
USD 3950.00
(Single User License)
Global AI-assisted Diagnostic Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI-assisted Diagnostic Software market size was US$ 1876 million in 2025 and is forecast to reach a readjusted size of US$ 4298 million by 2032 with a CAGR of 12.4% during the forecast period 2026-2032.
Published Date: 2026-06-18
Pages: 110
USD 4250.00
(Single User License)
Global AI-assisted Diagnostic Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI-assisted Diagnostic Software market is projected to grow from US$ 1876 million in 2025 to US$ 4298 million by 2032, at a CAGR of 12.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-06-18
Pages: 121
USD 4900.00
(Single User License)
AI-assisted Diagnostic Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-assisted Diagnostic Software was estimated to be worth US$ 1876 million in 2025 and is projected to reach US$ 4298 million, growing at a CAGR of 12.4% from 2026 to 2032.
Published: 2026-07-09
Pages: 107
USD 3950.00 (Single User License)Global AI-assisted Diagnostic Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI-assisted Diagnostic Software market size was US$ 1876 million in 2025 and is forecast to reach a readjusted size of US$ 4298 million by 2032 with a CAGR of 12.4% during the forecast period 2026-2032.
Published: 2026-06-18
Pages: 110
USD 4250.00 (Single User License)Global AI-assisted Diagnostic Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI-assisted Diagnostic Software market is projected to grow from US$ 1876 million in 2025 to US$ 4298 million by 2032, at a CAGR of 12.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-06-18
Pages: 121
USD 4900.00 (Single User License)
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now